Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET)
Clinical trial NCT06087276 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06087276
- Sponsor
- Praxis Precision Medicines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-02
- Primary completion
- 2025-10-10
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.